Hansa Biopharma AB (HNSBF)
2.90
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Hansa Biopharma Shareholders Equity (Quarterly) : -28.90M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -28.90M |
| December 31, 2025 | -9.653M |
| September 30, 2025 | -59.62M |
| June 30, 2025 | -46.28M |
| March 31, 2025 | -62.27M |
| December 31, 2024 | -53.38M |
| September 30, 2024 | -31.56M |
| June 30, 2024 | -20.66M |
| March 31, 2024 | -35.00M |
| December 31, 2023 | -16.66M |
| September 30, 2023 | -5.726M |
| June 30, 2023 | 16.87M |
| March 31, 2023 | 39.99M |
| December 31, 2022 | 57.86M |
| September 30, 2022 | 31.07M |
| June 30, 2022 | 47.04M |
| March 31, 2022 | 68.24M |
| December 31, 2021 | 83.67M |
| September 30, 2021 | 102.82M |
| June 30, 2021 | 120.58M |
| March 31, 2021 | 131.92M |
| December 31, 2020 | 151.25M |
| September 30, 2020 | 149.52M |
| Date | Value |
|---|---|
| June 30, 2020 | 40.58M |
| March 31, 2020 | 47.84M |
| December 31, 2019 | 60.12M |
| September 30, 2019 | 67.95M |
| June 30, 2019 | 81.42M |
| March 31, 2019 | 90.03M |
| December 31, 2018 | 96.99M |
| September 30, 2018 | 56.93M |
| June 30, 2018 | 60.69M |
| March 31, 2018 | 70.66M |
| December 31, 2017 | 77.03M |
| September 30, 2017 | 20.57M |
| June 30, 2017 | 23.55M |
| March 31, 2017 | 26.89M |
| December 31, 2016 | 31.23M |
| September 30, 2016 | 16.20M |
| June 30, 2016 | 18.91M |
| March 31, 2016 | 23.55M |
| December 31, 2015 | 25.09M |
| September 30, 2015 | 27.43M |
| June 30, 2015 | 29.42M |
| March 31, 2015 | 4.582M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioArctic AB | 230.74M |
| Swedish Orphan Biovitrum AB | 4.238B |
| Diamyd Medical AB | 18.82M |
| BONESUPPORT HOLDING AB | 98.56M |
| BioInvent International AB | 46.09M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.00M |
| Total Liabilities (Quarterly) | 150.89M |
| Debt to Equity Ratio | -4.150 |
| Current Ratio | 3.630 |
| Net Debt Paydown Yield | -1.54% |